AzTrials
AzTrials

AnxietyNCT06943105

Nonviolent Communication for Parents

A study testing Nonviolent Communication Intervention in people with Anxiety and Depression Symptom, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomised controlled trial (RCT) aims to evaluate the effectiveness of face-to-face Nonviolent Communication (NVC) intervention in improving parents' mental well-being and NVC skills, reducing parenting stress, depression and anxiety symptoms, and child emotional and behavioural problems. Read more about this study

Who is it for?
Ages 24 to 59 years
Conditions the study is for
Anxiety, Depression Symptom, Well-being
What is being tested?
Nonviolent Communication Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
174 participants
Where
1 siteHong Kong
Study dates
1 May 2025to 30 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1) parents aged 24-59 years with children of primary school age;
  • 2) with mild to severe depressive symptoms (score >5 on the Patient Health Questionnaire (PHQ)-9) (Kroenke et al., 2001) and/or mild to severe anxiety symptoms (score >5 on the General Anxiety Disorder (GAD)-7) (Spitzer et al., 2006); and
  • 3) Hong Kong residents who can understand Cantonese.

Who cannot join

  • 1) under psychiatric treatment, psychotherapy groups and are classified as unstable cases based on the judgment of the recruiting social workers;
  • 2) participating in other related parenting programmes.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The Jockey Club Institute of Healthcare of Hong Kong Metropolitan University

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Effectiveness of Group-based Nonviolent Communication Interventions for Improving Mental Well-being in Parents: a Randomised Controlled Trial

This randomised controlled trial (RCT) aims to evaluate the effectiveness of face-to-face Nonviolent Communication (NVC) intervention in improving parents' mental well-being and NVC skills, reducing parenting stress, depression and anxiety symptoms, and child emotional and behavioural problems.

A total of 172 parents with primary-school-age children will be recruited and randomly assigned to an intervention group or a waitlist control group. The intervention group will receive six weekly 1.5-hour face-to-face NVC training sessions delivered by trained social workers.

Read more

Five to ten social workers will be trained by professional NVC trainers through a train-the-trainer workshop, including three sessions. Each social worker will be assessed before (TTT1), after (TTT2) the workshops and 10 months (TTT3).

Assessments for participants will be conducted at baseline (T1), immediately post-intervention (T2), and at three-month follow-up (T3). After completing the assessments, the waitlist control group will receive the same sessions. Qualitative interviews will be conducted to explore participants' experiences and perceptions of NVC.

Being tested
Nonviolent Communication Intervention
Keywords
Nonviolent Communication, parents, Depressive Symptoms, Anxiety
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nonviolent Communication InterventionBehavioural

    The intervention will be conducted by social workers who will be trained by professional NVC trainers through a train-the-trainer workshop, including six sessions. The interventions include an introduction to four fundamental principles of NVC, distinguishing observations from evaluations, identifying and expressing feelings, taking responsibility for feelings and needs, and using positive action language to make requests. Each session will feature a review of the previous session, a warm-up game and an exercise to consolidate the learning of the concepts. The intervention sessions will also include group discussions and debriefing sessions on parents' experiences of practising NVC.

Study groups in NCT06943105
Study groupRoleWhat they receive
Receiving NVC InterventionsExperimentalParticipants in the intervention group will receive six weekly 1.5-hour face-to-face NVC training sessions delivered by trained social workers.
Receives: Behavioral: Nonviolent Communication Intervention
Wailist Control GroupNo interventionThe waitlist control group will not receive any training before all the assessments have been done by both groups. The wailist control group will receive NVC training sessions after all assessments. During the whole study period, these participants can access usual medical services, whether related or unrelated to mental health needs.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Well-being

    The Short Warwick-Edinburgh Mental Well-being Scale (SWEMWS) is a 7-item scale for assessing mental health in non-clinical populations. Using a 5-point Likert scale (1 = none of the time, 5 = all the time), the total score is calculated by summing all seven items. The Chinese version showed good validity and reliability in the investigators' previous study. The congeneric reliability was 0.85 and the test-retest reliability was 0.70.

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

  2. NVC skills

    The measure of NVC skills was developed based on a 16-item scale that represents the four principles of NVC skills. Each item is rated on a 5-point scale ranging from 0 = never to 5 = always. The average score is calculated, with higher scores indicating better NVC skills. Cronbach's alpha was 0.82 in the investigators' pilot study.

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

Secondary outcomes (4)
  1. Parenting stress

    The Parental Stress Scale (PSS) is an 18-item questionnaire that assesses feelings about parents' parenting role. A 16-item version of the PSS was developed by Leung et al. for Hong Kong parents. Responses are given on a 5-point scale. The Chinese version showed good internal consistency (Cronbach's alpha: 0.86).

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

  2. Depressive symptoms

    The Patient Health Questionnaire (PHQ)-9 is a 9-item instrument that is commonly used to measure depressive symptoms in the past two weeks. Each item is rated on a 4-point scale ranging from 0 = not at all to 3 = nearly every day. The Chinese version showed good validity and reliability (Cronbach's alphas: 0.82-0.92).

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

  3. Anxiety

    The Generalized Anxiety Disorder (GAD)-7 scale is a 7-item instrument to assess generalised anxiety disorder in the past two weeks. The response options for the seven symptoms are the same as PHQ-9. The Chinese version showed good validity and reliability (Cronbach's alphas: 0.89-0.95).

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

  4. Child emotional and behavioural problems

    The Strengths and Difficulties Questionnaire (SDQ) is a 25-item emotional and behavioural screening questionnaire for children and young people. The version for the parents of 4-17-year-olds will be used. Each item is rated on a 3-point scale ('not true', 'somewhat true', 'certainly true'). The Chinese parent version showed good validity and reliability (Cronbach's alpha: 0.81).

    Measured: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2025
  2. Study start1 May 2025
  3. Primary completion31 May 2026
  4. Study completion30 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
174 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06943105
Sponsor's protocol ID
HE-RGC2024/NHS02
Status last verified
Aug 2026
First submitted
17 Apr 2025
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We are not sharing individual participant data (IPD) due to privacy concerns and limitations in participant consent. Although the data is de-identified, there remains a risk of re-identification, and participants were not explicitly consented for public data sharing. Aggregate results will be made available through publications and presentations to ensure transparency.

Questions about this trial

What is this clinical trial studying?

A study testing Nonviolent Communication Intervention in people with Anxiety and Depression Symptom, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Well-being (time frame: T1: Baseline; T2: Immediate post-intervention; T3: 3 months post-T2). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in